Quantcast

Latest T-cell lymphoma Stories

2014-05-12 23:08:25

ResearchMoz.us includes new market research report "Peripheral T-Cell Lymphomas PTCL Clinical Trials Review, H1, 2014" to its huge collection of research reports. Get detail report with TOC @ http://www.researchmoz.us/peripheral-t-cell-lymphomas-ptcl-global-clinical-trials-review-h1-2014-report.html. Albany, New York (PRWEB) May 12, 2014 Researchmoz presents this most up-to-date research on"Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H1, 2014".The...

2014-03-22 23:02:28

Researchers say a drug approved for the treatment of relapsed T-cell Non-Hodgkin’s Lymphoma may help people with indolent B-cell varieties, too. Raleigh, NC (PRWEB) March 22, 2014 Scientists studying the Non-Hodgkin’s Lymphoma drug Zolinza (vorinostat) say it may improve outcomes for patients fighting indolent B-cell lymphomas like follicular lymphoma and mantle cell lymphoma. The Phase II study, published in the British Journal of Haematology and reported by the Non-Hodgkin’s...

2014-02-24 23:26:06

Australian researchers say the combination of a psychiatry drug with a photosensitizer may work “synergistically” in patients with a certain kind of Non-Hodgkin’s Lymphoma. Raleigh, NC (PRWEB) February 24, 2014 The Non-Hodgkin’s Lymphoma Center is reporting on a new article in the Journal of Photochemistry and Photobiology detailing a promising new treatment for people with cutaneous T-cell lymphoma (CTCL), a variety of T-cell Non-Hodgkin’s Lymphoma involving the skin. Patients...

2012-06-18 05:43:06

(Ivanhoe Newswire) - NK/T-cell lymphoma is a very aggressive form of cancer, and currently has no effective treatment along with having a poor prognosis. This subtype of lymphoma is pretty rare in the United States, but is responsible for a large number of deaths in Asia, particularly China and Korea. A substantial proportion of NK/T-cell lymphomas harbor Janus Kinase 3 gene mutations. Patients with these lymphomas might benefit from treatment with a Janus Kinase inhibitor according to a...

2011-07-11 07:00:00

WHITE PLAINS, N.Y., July 11, 2011 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) is taking an aggressive and proactive approach to tackling the challenge of improving outcomes for cancer patients with particularly urgent needs. (Logo: http://photos.prnewswire.com/prnh/20110215/NY48642LOGO ) Earlier this year, LLS identified three underdeveloped but promising areas of research and sought proposals to help stimulate more academic research in these areas: the malignant stem...

2010-09-21 06:00:00

NEW YORK, Sept. 21 /PRNewswire/ -- While general awareness of lymphoma remains high, a new survey released today by the Lymphoma Research Foundation (LRF) reveals significant knowledge gaps among Americans about the disease, which is the most prevalent form of blood cancer in the United States. Survey results showed a high number of adults (86 percent) remain unaware that there are 67 different types of lymphoma - 61 types of non-Hodgkin lymphoma and six types of Hodgkin lymphoma. The...

2010-09-14 06:30:00

PHILADELPHIA, Sept. 14 /PRNewswire/ -- TenX Biopharma, Inc. announced today that data from a Phase II trial of zanolimumab (HuMax-CD4®) in peripheral T-cell Lymphoma (PTCL) were published in the British Journal of Haematology (Sep 2010: 150(5):565-73). The Hx-CD4-109 trial was designed to evaluate the safety and efficacy of zanolimumab in patients who have relapsed or refractory non-cutaneous peripheral T-cell lymphoma. Twenty-one adult patients with relapsed or...

2010-07-27 08:00:00

WHITE PLAINS, N.Y. and CAMBRIDGE, Mass., July 27 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and Shape Pharmaceuticals announced today that they have entered into a partnership to advance Shape's novel, topical treatment for cutaneous T-Cell lymphoma (CTCL) into clinical development. The compound, SHP-141, is a first-in-class topical histone deacetylase inhibitor with the potential to treat both early- and late-stage CTCL. Through the partnership, LLS will provide funding of...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related